ReplyWe thank Dr. Gallo, Dr. Mrazek, and Dr. Petrek for their interest in our work. We generally agree with their comments regarding its limitations. Indeed, we addressed these limitations in our article. 1 We are aware that multiple factors can influence the time to loosening, that is, inconvenient implants, surgical inexperience, low grade sepsis but it is also known that Il-6 is a key factor in particle induced osteolysis and might be a potential target for further investigations like we did. 2 This study is one of the first studies analyzing the impact of genetic background in relation to time to aseptic loosening. The results are preliminary and should be interpreted with some caution. We stated explicitly that a limited number of patients was investigated. However, we do not agree with Gallo and coworkers regarding their remarks to statistics and sample size determination. Their suggestions and the cited articles are dealing with genetic data in relation to dichotomous variables (i.e., no failure vs. failure) which would lead to contingency tables. 3,4 Our approach was the assessment of the time dependence of this failure with respect to different genotypes, which typically leads to Kaplan-Meier curves and survival analysis. 5 Our results support the concept of a role of GNAS1 genotype in aseptic loosening. Nevertheless, further independent (prospective) studies are necessary to back up the general findings and deduced hypothesis. Independent of this specific polymorphism, we believe that mapping the genetic background could lead to a better understanding of pathomechanisms and the development of individual therapeutic concepts.